HCV/HIV/HBV NAT Discriminatory

Also Known as (Alias) Individual HCV, HIV, HBV NAT by AmpliScreen
NAT by PCR
Discriminatory by Ampliscreen
Indications Use as a donor screening assay for HCV, HIV-1, or HBV
Use as a supplemental test for confirmatory testing
Discrimination of MPX NAT positive results
Blood donor reentry testing
Method Roche COBAS AmpliScreen NAT
Test Information Assay is a qualitative test for the direct detection of HCV, HIV-1, or HBV nucleic acid in human plasma. 
Sample Requirements Plasma (EDTA)
Requested Volume 6 mL
Minimum Volume or Pediatric volume 3 mL
Sample Information Further samples types and storage conditions:  Sample Acceptability for Nucleic Acid Testing (LINK)
Shipping Information Samples are acceptable for 5 days at a combination of room temperature (≤ 25°C) and at 2-8°C.
Requisition Form Donor Testing RFT
Transaction Code 3078-10
CPT Codes HCV:  87521
HIV:  87535
HBV:  87516
Test Schedule At least twice per week; days vary
Turn around Time (analytic time) 1200 PM Next Day; STAT testing available for organ transplantation
Report/ Results Positive, Negative, or Reactive, Nondiscriminating